Medi Assist Healthcare Services has announced a corporate share buyback proposal through the tender offer route, with the board setting 20 November 2026 as the official record date. Headquartered in Bengaluru, the health-tech and insurance-tech enterprise specializes in managing health benefits for corporate employers, retail members, and government public health programs, operating primarily through its subsidiary Medi Assist Insurance TPA.
Corporate Profile and Business Model
Founded in June 2000, the company functions as a third-party administrator (TPA) bridging insurance companies, policyholders, and medical institutions. When insured individuals undergo hospital treatment, the TPA subsidiary facilitates cashless hospitalization approvals and manages claim processing on behalf of underwriters. Additionally, the company administers comprehensive group health insurance plans for large corporate clients, streamlining paperwork and coordination.
According to corporate filings, Medi Assist was the pioneering TPA in India to administer in excess of INR 10,000 crore in active retail and group healthcare premiums. The enterprise is listed on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE).
Buyback Structure and Timeline
The board of directors approved the buyback proposal following an intimation on 27 October 2026 and formal approval on 30 October 2026. Structured under the board approval route since the outlay stays within 10% of the paid-up equity share capital and free reserves, the buyback encompasses 1,15,9199 equity shares representing 1.55% of the total paid-up equity share capital. The total financial outlay for the buyback is valued at INR 49.27 crore.
| Buyback Parameter | Details |
|---|---|
| Board Meeting Intimation | 27 October 2026 |
| Buyback Approval Date | 30 October 2026 |
| Record Date | 20 November 2026 |
| Buyback Price | INR 425 per share |
| Market Price on Approval | INR 296.75 per share |
| Premium on Market Price | 43.22% |
| Offer Size (Shares) | 11,59,199 shares |
| Offer Size (Amount) | INR 49.27 crore |
| Offer Type | Tender Offer |
| Face Value | INR 5 per share |
| Exchanges | BSE, NSE |
The promoter and promoter group, holding 4.61% of the equity as of 30 September 2026, have indicated they will not participate in the buyback tender offer. Shareholders owning shares as of the record date can tender their holdings through registered brokers.
Financial Performance Overview
An evaluation of the financial data reported by Medi Assist Healthcare Services demonstrates steady top-line expansion across recent fiscal periods, accompanied by fluctuations in net income.
Participation Mechanics and Entitlement
Small shareholders—defined as those holding shares valued below INR 2,00,000 on the record date—face an estimated entitlement ratio of 2.40% based on calculations by market trackers. Investors holding shares in dematerialized (demat) form must instruct their stockbrokers regarding the specific quantity they wish to tender, followed by a transfer to the clearing corporation’s designated special account.
For physical shareholders, original share certificates must be submitted alongside valid documentation to the broker, who then places the exchange order and forwards the transaction registration slip to the registrar.
Market and Business Analysis
Market Impact and Shareholder Sentiment
The announcement of a tender buyback at INR 425 per share provides a substantial 43.22% premium over the market price of INR 296.75 recorded on the approval date. Such a pricing structure typically boosts short-term retail investor engagement, as the spread between the prevailing market valuation and the buyback offer price creates an incentive for eligible holders to participate. However, because the total buyback size is restricted to INR 49.27 crore and 1.55% of the paid-up capital, overall acceptance ratios will heavily depend on total participation rates across small and general categories.
Company and Financial Impact
From a fundamental standpoint, Medi Assist demonstrates consistent revenue expansion, with total income scaling from INR 635 crore in FY 2024 to INR 905 crore in FY 2026. Net income experienced growth from INR 69 crore to INR 92 crore between FY 2024 and FY 2025, before moderating slightly to INR 89 crore in FY 2026 as total expenses rose to INR 730 crore. Deploying INR 49.27 crore toward a share buyback indicates management’s capital allocation strategy to return surplus cash to shareholders while optimizing the equity base.
Valuation and Capital Efficiency
With a face value of INR 5 per share and a buyback price set at INR 425, the transaction values the repurchased equity at a significant premium over recent market quotes. Small shareholders utilizing the maximum permissible limit of INR 2,00,000 would target approximately 471 shares based on the approval-date valuation of INR 296.75, resulting in an estimated investment outlay of INR 1,39,769.25. Actual profit realizations will fluctuate subject to final acceptance ratios published after the tender window concludes.
Key Takeaways
- Medi Assist Healthcare Services announced a share buyback of 11,59,199 equity shares valued at INR 49.27 crore.
- The buyback price is fixed at INR 425 per share, offering a 43.22% premium over the market price of INR 296.75 on the approval date.
- The official record date for identifying eligible shareholders is 20 November 2026.
- Total income grew from INR 635 crore in FY 2024 to INR 905 crore in FY 2026, accompanied by net income of INR 89 crore in FY 2026.
- Promoters holding 4.61% of the company have opted not to participate in the tender offer.
Frequently Asked Questions
The Medi Assist buyback record date is 20 November 2026.
The Medi Assist buyback price is INR 425 per share.
Medi Assist buyback is a tender offer.
The buyback offer size is 11,59,199 shares amounting to INR 49.27 crore.
The closing price of the stock as of 30 October 2026 was INR 296.75 per share.
